TABLE 6.

Docking results ± SD of (1), (2), (SB), (BTZ), and anticancer drugs to LIF (1emr) (kcal mol⁻¹)

	(1)	(2)	(SB)	(BTZ)	Lenalidomide	5‐FU
Estimated free binding energy[ a ]	−7.20 ± 0.04	−8.43 ± 0.01	−7.07 ± 0.20	−5.52 ± 0.01	−7.39 ± 0.01	−4.60 ± 0.01
Final intermolecular energy	−8.39 ± 0.04	−9.32 ± 0.01	−8.86 ± 0.20	−5.81 ± 0.01	−7.99 ± 0.01	−5.19 ± 0.01
vdW + Hbond + desolve energy	−7.17 ± 0.04	−8.87 ± 0.02	−6.5 ± 0.35	−5.74 ± 0. 11	−7.95 ± 0.05	−2.77 ± 0.04
Electrostatic energy	−1.22 ± 0.02	−0.44 ± 0.01	−2.35 ± 0.19	0.51 ± 0.01	−0.03 ± 0.02	−2.41 ± 0.04
Final total internal energy	−1.93 ± 0.40	0.89 ± 0.01	−0.76 ± 0.04	−0.23 ± 0.01	−0.23 ± 0.21	0.57 ± 0.01
Torsional free energy	1.19 ± 0.01	−0.44 ± 0.01	1.79 ± 0.01	0.3 ± 0.01	0.60 ± 0.01	0.60 ± 0.01
Unbound system's energy	−1.93 ± 0.40	−1.74 ± 0.80	−0.76 ± 0.04	−0.23 ± 0.01	−0.23 ± 0.21	0.57 ± 0.01

Abbreviation: 5‐FU, 5‐fluorouracil.

^a ΔG _binding = ΔG _{vdW + hb + desolve} + ΔG _elec + ΔG _total + ΔG _tor − ΔG _unb.